As shown in Figure 5, the growth rate (tumor volume change per a given time period) of NT shRNA-pHEX6300 (n = 6) was significantly faster than that of FGFR1 shRNA-pHEX6300 (n = 8) (p < 0.0001, two-way ANOVA) (Figure 5(a)), and the similar result was seen when the rate of FGFR1 shRNA-LDHA was compared with that of FGFR1 shRNA-pHEX6300 (p < 0.0001, two-way ANOVA, n = 8) (Figure 5(a)). Here, LDHA is linked to neoplasm.